COMP <GO>
KOD vs UNH // 10Y YIELD & FRED MACRO BETA
Kodiak Sciences Inc (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: KOD 3
— UNH 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: KOD
LAST: $98.89 (+1.30%) • MKT CAP: $6.14B
macro-sensitivity
0.90
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (KOD VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | KOD | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 88.31% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | 12.38% | -47.38 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.16% | 6.25% | -8.41 | UNH | /fcf-yield <GO> |
| Operating Margin | -13.30% | 5.32% | -18.62 | UNH | /operating-margins <GO> |
| Net Profit Margin | -13.00% | 3.53% | -16.53 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | 3.33% | -2.23 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 16.70 | 3.09 | +13.61 | KOD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 7/9 | -3.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.0 | 55.1 | +7.90 | KOD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.90 | 0.33 | +0.57 | KOD | /macro-sensitivity <GO> |
| Forward P/E Multiple | 35.0x | 17.7x | +17.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.14B | $359.43B | -$353.30B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | KOD REV | UNH REV | KOD GROSS % | UNH GROSS % | KOD FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $656.3M | $447.57B | — | 88.7% | -$136.5M | $16.07B |
| FY 2024 | $523.2M | $400.28B | — | 88.3% | -$117.7M | $20.70B |
| FY 2023 | $776.5M | $371.62B | — | 89.6% | -$154.2M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
KOD // BETA 0.90
UNH // BETA 0.33